What Causes Uptake of Technetium-99m Methylene Diphosphonate by Tumors? A Case Where the Tumor Appeared to Secrete a Hypercalcemia-Causing Substance

Charles K. Stone; James C. Sisson

Case ReportClinical Sciences

What Causes Uptake of Technetium-99m Methylene Diphosphonate by Tumors? A Case Where the Tumor Appeared to Secrete a Hypercalcemia-Causing Substance

Charles K. Stone and James C. Sisson

Journal of Nuclear Medicine March 1985, 26 (3 Part 1) 250-251;

Charles K. Stone

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

James C. Sisson

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 26, Issue 3 Part 1

March 1, 1985

Table of Contents
Table of Contents (PDF)
Index by author
Advertising (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following What Causes Uptake of Technetium-99m Methylene Diphosphonate by Tumors? A Case Where the Tumor Appeared to Secrete a Hypercalcemia-Causing Substance

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

What Causes Uptake of Technetium-99m Methylene Diphosphonate by Tumors? A Case Where the Tumor Appeared to Secrete a Hypercalcemia-Causing Substance

Charles K. Stone, James C. Sisson

Journal of Nuclear Medicine Mar 1985, 26 (3 Part 1) 250-251;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

What Causes Uptake of Technetium-99m Methylene Diphosphonate by Tumors? A Case Where the Tumor Appeared to Secrete a Hypercalcemia-Causing Substance

Charles K. Stone, James C. Sisson

Journal of Nuclear Medicine Mar 1985, 26 (3 Part 1) 250-251;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Clinical Sciences

Estimation of Technetium-99m-MAG₃ Plasma Clearance in Adults from One or Two Blood Samples
Nonimmunogenic Hyperthyroidism: Cumulative Hypothyroidism Incidence After Radioiodine and Surgical Treatment
Diagnosis of Coronary Artery Disease by Radionuclide Angiography: Effect of Combining Indices of Left Ventricular Function

Show more Clinical Sciences

Case Report

Regression of Advanced Refractory Ovarian Cancer Treated with Iodine-131-Labeled Anti-CEA Monoclonal Antibody
Graves′ Disease Triggered by Autoinfarction of an Autonomously Functioning Thyroid Adenoma
Technetium-99m-MDP Uptake in Hilar Lymph Nodes in Sarcoidosis

Show more Case Report

Main menu

User menu

Search

What Causes Uptake of Technetium-99m Methylene Diphosphonate by Tumors? A Case Where the Tumor Appeared to Secrete a Hypercalcemia-Causing Substance

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Clinical Sciences

Case Report

Similar Articles